Breast Aesthetics by Three Dimensional Measures

Summary

Traditionally the measures of the optimally aesthetic breast have been assumed to be static and to represent universal values (1). Measures developed for optimal aesthetic results in breast reduction were derived from brassiere patterns and then applied universally (2). These early and important papers still strongly influence the view of the aesthetics of the breast despite the lack of individualisation and proportion.

To create satisfying results for specific patients, optimal proportions angles and relative measures are needed for each patient. The study will clarify theses measures and provide important guidelines for surgeons.The data will also help define optimal proportional aesthetics in the individual patient.

The concept of universal beauty is unrealistic. It has always been taken for granted that aesthetic values from all cultures are similar. Using 3D scanning on volunteers of youthful age offers a complex set of data that may distinguish fine differences in aesthetic ideals in different cultures.

Little is known about how life events and life-style factors affect breast aesthetics.

To follow a population with 3D scans over 5, 10 and 15 years will allow aesthetic ratings to be correlated with life events such as pregnancy, childbirth, breast-feeding and life style factors such as smoking.

The study will improve the understanding of breast aesthetics in general, in different cultures and in relation to life events and life style factors. No similar studies have previously been performed.

Conditions

• Breast Cancer

Interventions

DIAGNOSTIC_TEST

Aesthetic assessment 3D breast scanning

Vectra TM - Canfield Inc breast scan. 3D digital photography scan.

Sponsors & Collaborators

• M.D. Anderson Cancer Center

  collaborator OTHER

• University College of Southeast Norway

  collaborator OTHER

• Skintech A/S

  collaborator UNKNOWN

• Canfield Inc

  collaborator UNKNOWN

• Oslo University Hospital

  collaborator OTHER

• Karolinska Institutet

  collaborator OTHER

• University of Helsinki

  collaborator OTHER

• Sykehuset Telemark

  lead OTHER_GOV

Principal Investigators

• Lars Johan M Sandberg, MD, FACS · STHF

Eligibility

Min Age

18 Years

Max Age

35 Years

Sex

FEMALE

Healthy Volunteers

No

Timeline & Regulatory

Start

2016-05-13

Primary Completion

2032-03-20

Completion

2032-03-20

Countries

• Norway

Study Locations